Serum and CSF Neurofilament Light Levels Predict Long-Term Outcomes in Multiple Sclerosis Patients

被引：0

作者：

Kuhle, Jens ^{[1
,2
]}

Plavina, Tatiana ^{[3
]}

Barro, Christian ^{[1
,2
]}

Sangurdekar, Dipen ^{[3
]}

Singh, Carol ^{[3
]}

DeMoor, Carl ^{[3
]}

Engle, Bob ^{[3
]}

Fisher, Elizabeth ^{[3
]}

Kappos, Ludwig ^{[1
,2
]}

Rudick, Richard ^{[3
]}

Goyal, Jaya ^{[1
,2
]}

机构：

[1] Univ Hosp Basel, Neurol Clin & Policlin, Dept Med, Basel, Switzerland

[2] Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed & Clin Res, Basel, Switzerland

[3] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA

来源：

NEUROLOGY | 2017年 / 88卷

基金：

瑞士国家科学基金会;

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S50.005

引用

页数：2

共 50 条

[11] Serum neurofilament light chain levels predict thalamic volume loss in multiple sclerosis
Magon, S.
Schaedelin, S.
Barro, C.
Tsagkas, C.
Chakravarty, M.
Gaetano, L.
Naegelin, Y.
Benkert, P.
Amann, M.
Parmar, K.
Papadopoulou, A.
Wuerfel, J.
Yaldizli, O.
Oechtering, J.
Leppert, D.
Sprenger, T.
Kappos, L.
Granziera, C.
Kuhle, J.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 501 - 502
[12] Long-term Effect of Fingolimod in Reducing Blood Neurofilament Light Levels in Patients with Relapsing-remitting Multiple Sclerosis
Cohen, Jeffrey
Kappos, Ludwig
Tenenbaum, Nadia
Han, Jackie
Kropshofer, Harald
Tomic, Davorka
Kuhle, Jens
NEUROLOGY, 2019, 92 (15)
[13] Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial
Cutter, Gary
Rudick, Richard A.
de Moor, Carl
Singh, Carol M.
Fisher, Elizabeth
Koster, Thijs
Lublin, Fred D.
Wolinsky, Jerry S.
McFarland, Henry
Jacobson, Steven
Naylor, Maria L.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (02)
[14] Temporal variability profile of serum neurofilament light levels in multiple sclerosis patients
Calabresi, P. A.
Arnold, D. A.
Sangurdekar, D.
Singh, C. M.
De Moor, C.
Engle, B.
Goyal, J.
Deykin, A.
Fisher, E.
Kieseier, B. C.
Rudick, R. A.
Plavina, T.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 24 - 25
[15] Basal levels of serum neurofilament light in normal aging and multiple sclerosis patients
Gasque Rubio, R.
Villar, L. M.
Cubas Nunez, L.
Laiz, B.
Quintanilla Bordas, C.
Carratala Bosca, S.
Gil-Perotin, S.
Perez Miralles, F.
Alcala, C.
Castillo Villalba, J.
Casanova Estruch, B.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 525 - 525
[16] Combining levels of serum neurofilament light chain with CSF glial fibrillary acidic protein improves the prediction of long-termclinical outcomes in multiple sclerosis
Thebault, S.
Fereshtehnejad, S. -M.
Bose, G.
Abdoli, M.
Freedman, M. S.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 960 - 960
[17] Long-term outcomes in patients with multiple sclerosis
Bates, David
NEUROLOGY, 2011, 76 (01) : S1 - S2
[18] Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
Canto, Ester
Barro, Christian
Zhao, Chao
Caillier, Stacy J.
Michalak, Zuzanna
Bove, Riley
Tomic, Davorka
Santaniello, Adam
Haering, Dieter A.
Hollenbach, Jill
Henry, Roland G.
Cree, Bruce A. C.
Kappos, Ludwig
Leppert, David
Hauser, Stephen L.
Benkert, Pascal
Oksenberg, Jorge R.
Kuhle, Jens
JAMA NEUROLOGY, 2019, 76 (11) : 1359 - 1366
[19] Serum neurofilament light chain levels as multiple sclerosis biomarker
Abd-ElHady, Mohamed E.
Hashish, Ehab
Yassine, Imane
Anani, Maha
Negm, Mohamed
PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2024, 28 (02) : 28 - 32
[20] Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?
Kalatha, Thaleia
Arnaoutoglou, Marianthi
Koukoulidis, Theodoros
Hatzifilippou, Eleni
Bouras, Emmanouil
Baloyannis, Stavros
Koutsouraki, Effrosyni
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (05) : 2187 - 2198

← 1 2 3 4 5 →